InnoPharmax Inc., a specialty pharmaceutical company, develops and commercializes products for the treatment of oncology and other specialties in Taiwan. The company offers Imipenem and Cilastatin sodium solution under the Bestnem brand for the treatment of infections caused by susceptible organisms, such as lower respiratory tract, skin and skin structure, intra-abdominal, gynecologic, bone, and joint infections; contrast agents, such as gadopentetate dimeglumine under the Gadomni brand; oncology agents comprising bendamustine under the …
Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
1,369,139,456
Fair value reference
17.32
Next-week expectancy
Negative · 37.44%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-14, 4172 fell 7.66%, moving from 12.40 to 11.45. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -50.55 and has improved across the 12-week window. Market Dynamics is -0.70 on the latest week. Next-week expectancy is negative at 37.44% based on similar historical setup states.
Week Ending
14 Aug 2026
Latest Close
11.45
12-Week Change
-7.66%
Trend Signal
Inactive
Next-Week Expectancy
Negative 37.44%
Signal Weeks
0 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Resistance
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateBelow accepted value
52-week position
9.9%
Low to high
Accepted price
16.07
Latest versus accepted: -28.76%
Fitted direction
Falling
-1.86% per week
Range pressure
36/100
Balanced pressure
Range condition
Contracting
0.72× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support10.75
From price
-6.1%
Evidence
38/100
Touches
1
Support11.20
From price
-2.2%
Evidence
36/100
Touches
1
Resistance12.70
From price
10.9%
Evidence
45/100
Touches
2
Resistance16.00
From price
39.7%
Evidence
100/100
Touches
6
Resistance16.75
From price
46.3%
Evidence
81/100
Touches
3
Current reading
What the range shows
Current positionBelow accepted value
Price is at 9.9% of its latest 52-week range.
Fitted directionFalling
The fitted centre line is moving -1.86% per week.
Range pressureBalanced pressure
The current pressure reading is 36/100; 50 is balanced.
Next structural level11.20
Support is 2.2% from the latest close with 36/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
14 Aug 2026
Latest Close
11.45
12-Week Change
-7.66%
Trend Signal
Inactive
Next-Week Expectancy
Negative 37.44%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-50.55
Market Dynamics
-0.70
Over the latest 12 completed weeks ending 2026-08-14, 4172 fell 7.66%, moving from 12.40 to 11.45. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -50.55 and has improved across the 12-week window. Market Dynamics is -0.70 on the latest week. Next-week expectancy is negative at 37.44% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
